Company Description
SONUS Pharmaceuticals, Inc.. The Company's principal activity is to develop oncology drugs that provide better therapeutic alternatives for cancer patients, including improved efficacy, safety, tolerability and are more convenient to use. The ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
S
Sonus Pharmaceuticals
Engaged in the research and development of proprietary ultrasound contrast agents and drug delivery systems.
www.sonuspharma.com
Engaged in the research and development of proprietary ultrasound contrast agents and drug delivery systems.
www.sonuspharma.com
Breaking News
Forbes.com - November 05, 2009 1:59 PM
BOTHELL, WA and VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ('OncoGenex' or the 'Company') (NASDAQ: OGXI) today reported unaudited financial results for the third quarter and nine months ended September 30, 2009 and reviewed ...
Courier Logistics Systems
Technology for Delivery Needs Courier Management and Tracking
www.ecouriersoftware.com
Technology for Delivery Needs Courier Management and Tracking
www.ecouriersoftware.com
